We think dividend-paying quality pharmaceutical stocks Pfizer Inc, Merck & Co., Inc, and Bristol-Myers Squibb Company could be solid additions to one’s portfolio now to secure a steady income stream.

One of the biggest events in healthcare annually, the American Society of Hematology’s annual meeting (56th!) begins on December 6, but abstracts from the conference will be released this morning. Here's a primer on the stocks to watch.

Dividend-paying stocks do better than their non-dividend-paying peers.

Bristol-Myers posts outstanding results In lung cancer data using immunotherapy drug

U.S. stocks climbed in afternoon trading on Tuesday, following stronger-than-expected earnings and an upbeat consumer confidence reading.

Better to let the market tell you when that retracement ends than to try to impose your opinions on the market.